Emerging therapeutic options for the management of hepatitis C infection

doi:10.3748/wjg.v20.i23.7079

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 23

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5991)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

355

WORD

177

HTML

3189

Figures (1-1)

209

Tables (1-2)

175

Sum=4105

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1008

Download

878

Sum=1886

Jun 21, 2014 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 21, 2014; 20(23): 7079-7088
Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7079

Table 2 Additional drugs in development for hepatitis C

NS5A hepatitis C virus replication inhibitors

Daclatasvir

Ledipasvir

ACH-3102

ABT-267

NS5B RNA dependent RNA polymerase inhibitors

Sofosbuvir

Mericitabine

ABT-333

Host targeted agents

Alisporivir

Miravirsen

Interferon-λ

Citation: Thompson JR. Emerging therapeutic options for the management of hepatitis C infection. World J Gastroenterol 2014; 20(23): 7079-7088
URL: https://www.wjgnet.com/1007-9327/full/v20/i23/7079.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i23.7079